Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Silencing of Rho GTPases Cdc42, Rac1 or RhoA reduces PDGFRα and -β phosphorylation and downstream signaling of STAT1 and STAT3
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences. (Johan Lennartsson)ORCID iD: 0000-0003-1195-3539
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences. Uppsala University, Science for Life Laboratory, SciLifeLab.ORCID iD: 0000-0003-0135-9560
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.ORCID iD: 0000-0002-0915-5303
(English)Manuscript (preprint) (Other academic)
Abstract [en]

Platelet-derived growth factor receptors (PDGFR) have been implicated in both pathological and physiological signaling and play a major role in the homeostasis of the tumor microenvironment. It has previously been shown that Cdc42, which belongs to the family of Rho GTPases, impairs the degradation of EGFR and VEGFR2. In the current work, we have investigated how Cdc42 as well as Rac1 and RhoA affect PDGFRα and -β signaling and downstream activation of AKT, ERK1/2, STAT1 and STAT3. In response to individual depletion of all Rho GTPases both PDGFRα and -β show a significant reduction in their phosphorylation. We could see a delayed internalization in response to Cdc42 or Rac1 depletion and an increased steady-state amount in response to RhoA depletion for both PDGFRα and -β. Downstream of both receptors, we saw a dramatic effect on STAT signaling, however, AKT and ERK1/2 signaling was unaffected. PDGF-BB-induced STAT1 and STAT3 phosphorylation was severely impaired in response to the depletion of either Cdc42, Rac1 or RhoA. Furthermore, STAT1 protein levels were also decreased in response to depletion of the Rho GTPases. In conclusion, we show that both PDGFRα and PDGFRβ rely on Cdc42, Rac1 and RhoA for proper signaling. Furthermore, we also show that STAT1 and STAT3 depend on Cdc42, Rac1 and RhoA for their signaling downstream of PDGFRs, and STAT1 for its protein stability.

National Category
Biochemistry and Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-531215OAI: oai:DiVA.org:uu-531215DiVA, id: diva2:1868723
Funder
Swedish Cancer Society, 21 1427 Pj 01H
Note

De två sista författarna delar sistaförfattarskapet

Available from: 2024-06-12 Created: 2024-06-12 Last updated: 2024-06-17Bibliographically approved
In thesis
1. Regulation and signal transduction of the platelet-derived growth factor receptor and the epidermal growth factor receptor
Open this publication in new window or tab >>Regulation and signal transduction of the platelet-derived growth factor receptor and the epidermal growth factor receptor
2024 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Receptor tyrosine kinases (RTKs) are crucial regulators of cellular processes, including growth, differentiation, and survival. They function by transmitting extracellular signals through membrane receptors to intracellular signaling pathways. Among these RTKs, the platelet-derived growth factor receptors (PDGFRs) and the epidermal growth factor receptor (EGFR) are vital for maintaining cellular homeostasis and are implicated in various pathological conditions, including cancer. In addition to these pathways, nuclear receptors such as the vitamin D receptor (VDR) also play a significant role in modulating cellular functions. The VDR regulates gene expression in response to the active form of vitamin D, and its cross-talk with RTK pathways offers a complex layer of regulatory control that affects cellular proliferation and differentiation.

This thesis investigates the complex signaling mechanisms of PDGFRs and EGFR, emphasizing the influence of lipid rafts, Rho GTPases, and cross-talk with vitamin D receptor (VDR) signaling.

Paper I focuses on the consequences of lipid raft disruption on PDGFR-β signaling. The research highlights that disrupting lipid rafts alters the association of PDGFR-β with some of its downstream signaling components, reducing the activity of ERK1/2 and AKT in BJ-hTERT fibroblasts and AKT and Src in U2OS osteosarcoma cells. 

Paper II explores the differential impact of cholesterol depletion on EGFR and PDGFR-β signaling. We found that EGFR and PDGFR-β internalize into distinct compartments after activation, converging only after prolonged stimulation. Cholesterol depletion enhanced EGFR dimerization and activation while reducing downstream AKT and ERK1/2 phosphorylation, suggesting distinct membrane microdomain dependencies for these receptors.

Paper III explores the impact of Rho GTPase depletion on the phosphorylation and internalization of PDGFR-α and -β. The findißngs suggest that the depletion of Cdc42, Rac1, or RhoA significantly diminishes PDGFR phosphorylation, and downstream stability of STAT1 and activation of STAT1 and STAT3 indicating that these Rho GTPases are integral for the optimal signaling of PDGFRs.

Paper IV examines the cross-talk between VDR and RTK signaling. We discovered that EGF, but not PDGF-BB, enhances VDR-mediated CYP24A1 expression, indicating a selective interaction between these pathways. Additionally, 1,25(OH)2-vitamin D3 inhibited PDGF-BB-induced proliferation and PDGFR-β phosphorylation, revealing a complex interplay.

Collectively, these studies elucidate the nuanced regulatory mechanisms of PDGFRs and EGFR, emphasizing the roles of lipid rafts, Rho GTPases, and cross-talk with nuclear receptors. 

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2024. p. 57
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 354
Keywords
Receptor Tyrosine Kinases (RTKs), Platelet-Derived Growth Factor Receptors (PDGFR), Epidermal Growth Factor Receptor (EGFR), Signal Transduction, Lipid Rafts, Rho GTPases, Vitamin D Receptor (VDR) Signaling, Endocytosis, Cross-Talk, AKT Pathway, STAT pathway, ERK1/2 Pathway.
National Category
Biochemistry and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-531567 (URN)978-91-513-2162-2 (ISBN)
Public defence
2024-09-06, B21, BMC, Husargatan 3, Uppsala, 09:15 (English)
Opponent
Supervisors
Funder
Swedish Cancer Society, 21 1427 Pj 01H
Available from: 2024-08-09 Created: 2024-06-14 Last updated: 2024-08-09

Open Access in DiVA

No full text in DiVA

Authority records

Wåhlén, ErikLennartsson, JohanHeldin, Johan

Search in DiVA

By author/editor
Wåhlén, ErikLennartsson, JohanHeldin, Johan
By organisation
Department of Pharmaceutical BiosciencesScience for Life Laboratory, SciLifeLab
Biochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 32 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf